PharmacoEconomics & Outcomes News

, Volume 803, Issue 1, pp 3–3 | Cite as

Aflibercept and rivaroxaban to be funded in New Zealand

News item


  1. PHARMAC. Thousands of New Zealanders will benefit from advances in treatment. Internet Document : 10 May 2018. Available from: URL:

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations